{
    "code": "52026206",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026206",
    "time": "2023-03-10 05:28:17",
    "許可證字號": "衛部藥輸字第026206號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/12\/02",
    "發證日期": "102\/12\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202620609",
    "中文品名": "利妥柔膜衣錠2.5毫克",
    "英文品名": "Lovizol Film-Coated Tablets 2.5 mg",
    "適應症": "接受抗動情激素治療失敗的自然或人工停經後之末期乳癌病人之治療。停經後之局部晚期或轉移性乳癌婦女患者之第一線治療用藥。荷爾蒙接受器呈陽性及LN METASTASIS POSITIVE之乳癌病人作為TAMOXIFEN輔助療法之後的延伸治療。停經後荷爾蒙接受器呈陽性反應的初期乳癌病人之輔助治療。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠PTP 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LETROZOLE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0039000  GENEPHARM S.A",
            "製造廠廠址": "18 km Marathon Avenue, 15351 Pallini-Greece\/ Greece",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCN0087000  ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "56 Binhai Road, Jiaojiang District, Taizhou City, Zhejiang, China",
            "製造廠公司地址": "",
            "製造廠國別": "CHINA",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FIN0024000  SUN PHARMACEUTICAL INDUSTRIES LIMITED",
            "製造廠廠址": "A-7\/A-8, M.I.D.C.,INDUSTRIAL AREA, AHMEDNAGAR-414 111,INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000400",
            "成分名稱": "LETROZOLE",
            "含量描述": "",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "ARTDB016772P-111-04-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=007&Type=9"
        },
        {
            "title": "Letrozole_Round_3_ARTDB016772P_clear-109-03-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=006&Type=9"
        },
        {
            "title": "03. Letrozole_propose PIL-108-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=005&Type=9"
        },
        {
            "title": "ARTDB021980F-111-04-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=010&Type=8"
        },
        {
            "title": "ARTDB018693C-111-04-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=009&Type=8"
        },
        {
            "title": "Letrozole_Round_3_ARTDB016771F_clear-109-03-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=008&Type=8"
        },
        {
            "title": "Letrozole_Round_3_ARTDB016770C_clear-109-03-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=007&Type=8"
        },
        {
            "title": "Foil-ArtworkApprovals_CompID_52_reg_5-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=006&Type=8"
        },
        {
            "title": "Carton-ArtworkProof_CompID_12270_Round_2-Signed-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026206&Seq=005&Type=8"
        }
    ]
}